1. Management of anaemia and iron deficiency in patients with cancer: ESMO Clinical Practice Guidelines. (3rd October 2018) Authors: Aapro, M; Beguin, Y; Bokemeyer, C; Dicato, M; Gascón, P; Glaspy, J; Hofmann, A; Link, H; Littlewood, T; Ludwig, H; Österborg, A; Pronzato, P; Santini, V; Schrijvers, D; Stauder, R; Jordan, K; Herrstedt, J Journal: Annals of oncology Issue: Volume 29(2018)Supplement 4 Page Start: iv271 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Long-term safety assessment of niraparib in patients with recurrent ovarian cancer: results from the ENGOT-OV16/NOVA trial. (1st November 2019) Authors: Mirza, MR; Dørum, A; Benigno, B; Mahner, S; Bessette, P; Bover Barcelo, IM; Berton, D; Ledermann, J; Rimel, BJ; Herrstedt, J; Lau, S; Canzler, U; Palacio Vázquez, I; Kalbacher, E; Buscema, J; Lorusso, D; Debruyne, P; Bruchim, I; Guo, W; Gupta, D Journal: International journal of gynecological cancer Issue: Volume 29(2019)Supplement 4 Page Start: A15 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Management of anaemia and iron deficiency in patients with cancer: ESMO Clinical Practice Guidelines. (20th February 2018) Authors: Aapro, M; Beguin, Y; Bokemeyer, C; Dicato, M; Gascón, P; Glaspy, J; Hofmann, A; Link, H; Littlewood, T; Ludwig, H; Österborg, A; Pronzato, P; Santini, V; Schrijvers, D; Stauder, R; Jordan, K; Herrstedt, J Journal: Annals of oncology Issue: Volume 29(2018)Supplement 4 Page Start: iv96 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗